GCC Syringes and Needles Market to Grow US$ 505.6 Mn at a CAGR of 9.1% by 2030 | Becton, Dickinson and Company, Nipro Corporation

Needles and syringes are sterile instruments used to inject substances into or remove fluids from the body. There are numerous types and styles of syringes on the market. Most of them are single-use and others even have needles already connected. Some syringes, however, may not have a needle already attached. Medications come in a variety of volumes, therefore the syringe must be chosen accordingly. Needles are straightforward medical devices that consist of a hollow barrel with a pointed tip and a hub that snaps onto the syringe.

In 2022, the Gulf Cooperation Council (GCC) syringes and needles market is projected to reach a value of US$252.3 Mn, expanding at a CAGR of 9.1% in the predicted period (2022-2030).

Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3472

Growth in the syringe and needle market in the GCC is anticipated to be driven by the rising incidence of chronic diseases.

Market expansion for syringes and needles is anticipated over the projected period due to the rising incidence of chronic diseases like as cancer, diabetes, cardiovascular disease, and others, which need their use in the medical analysis and care of these conditions. An estimated 73 Mn adults in the Middle East and North Africa (MENA) area of the world have diabetes in December 2021, according to research published by the International Diabetes Federation (IDF). By 2030, experts predict that number will rise to 95 Mn, and by 2045, it will reach 136 Mn in the MENA region.

Throughout the projected period, the market is expected to increase thanks to rising investments by major players in the region in the production of medical equipment, such as syringes.

Over the projection period, growth in the region’s market is anticipated to be driven by major domestic players stepping up their game and making investments in fields like medical device manufacturing with an eye toward export.To give just one example, in October of 2022, the United Arab Emirates pledged US$ 70 mn toward the production and export of medical equipment around the world. PureHealth, a UAE healthcare provider, collaborated with Abu Dhabi Medical Devices Company (ADMD), Abu Dhabi Ports Group, and polymers supplier Borouge to establish a manufacturing facility for medical supplies in Abu Dhabi as part of this effort. Raw materials will be supplied by Borouge, a joint venture of Abu Dhabi National Oil Company (Adnoc) and Austria-based Borealis, and industrial land will be supplied by Abu Dhabi Ports Group, the preeminent facilitator of logistics, industry, and trade in the region and a bridge connecting Abu Dhabi to the world. According to a second deal between PureHealth and pharmaceutical company Julphar, the first facility to produce Glargine, a long-acting biological alternative to insulin used to treat diabetes, will soon be up and running in the Middle East.

GCC Syringes and Needles Market– Effect of Coronavirus (COVID-19) Pandemic

One hundred nations have reported COVID-19 cases since the outbreak began in December 2019, causing the WHO to declare a worldwide public health emergency on 30^th January, 2020.

There are three main ways in which COVID-19 might damage the economy: through direct effects on production and need, through interruptions in distribution systems, and through monetary effects on businesses and financial markets. India, China, Egypt, Saudi Arabia, the United Arab Emirates, and others all experienced difficulties transporting goods from one location to another as a result of statewide lockdowns.

The enhanced COVID-19 immunization programs, however, had a favorable impact on the GCC syringes and needles market. The National Emergency Crisis and Disaster Management Authority, for example, reports that the United Arab Emirates (UAE) completed its National COVID-19 Vaccination Program and vaccinated and immunized all of its intended populations by the end of June 2022. The campaign’s intended recipients included healthy adults of the right age ranges for each vaccine, the elderly, and those with chronic disorders whose conditions allow vaccination.

GCC Syringes and Needles Market: Restraint

High fixed costs, low profit margins, and product recalls are the main issues holding back the GCC syringes and needles industry. For example, the syringe and needle business is volume driven but is expensive to produce due to high initial investment and ongoing maintenance. The need for a trained labor force also contributes to the industry’s high cost of doing business. Market demands for sterility mean strict adherence to regulations. Market expansion is likely to be hampered by all of these concerns.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/3472

Key Players

Companies like these dominate the Gulf Cooperation Council (GCC) syringe and needle market are Becton, Dickinson and Company, Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Medtronic plc., Smiths Group plc., Abu Dhabi Medical Devices Company, IBN Sina Medical Factory, Alshifa Medical Syringes Manufacturing Company Limited, International Korean Medical Company, Mais Saudia, and VITREX Medical A/S

Report Attribute	Details
The market size value in 2023	USD 252.3 million
The revenue forecast in 2030	USD 505.6 million
Growth Rate	CAGR of 9.1%%
The base year for estimation	2022
Historical data	2017 – 2021
Forecast period	2023 – 2030
Growth Drivers:	Increasing Healthcare Expenditure, Rising Prevalence of Chronic Diseases, Expansion of Healthcare Facilities, Vaccination Programs.
Restraints & Challenges:	Limited Local Manufacturing, Stringent Regulatory Requirements, Price Sensitivity, Counterfeit Products.

Table of Contents with Major Points:

Executive Summary

• Introduction
• Key Findings
• Recommendations
• Definitions and Assumptions

Market Overview

• Definition of GCC Syringes and Needles Market
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Trends and Developments

Key Insights

• Key Emerging Trends
• Key Developments Mergers and Acquisition
• New Product Launches and Collaboration
• Partnership and Joint Venture
• Latest Technological Advancements
• Insights on Regulatory Scenario
• Porters Five Forces Analysis

Qualitative Insights Impact of COVID-19 on Global GCC Syringes and Needles Market

• Supply Chain Challenges
• Steps taken by Government/Companies to overcome this impact
• Potential opportunities due to COVID-19 outbreak

Conclusion 

Appendix

• Data Sources
• Abbreviations
• Disclaimer

TOC Continued…!

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/3472

Why Choose Coherent Market Insights?

☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.

☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.

☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.

Explore More Related Insights:

Middle east and asia injectable drugs market

Special purpose needles market

Safety needles market

Syringes market